Companies / Impinj Inc / Activity
Activity — Impinj Inc
75 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | Diorio Chris Ph.d. CEO | Other | Common Stock | $28.20M | -180K -31.56% | 390,302 1.28% of shares | low |
| May 26, 2026 | Diorio Chris Ph.d. CEO | Other | Common Stock | $28.20M | +180K +46.12% | 570,302 1.87% of shares | low |
| May 29, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $7.31M | -49K -4.75% | 973,667 3.19% of shares | medium |
| May 7, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $5.52M | -36K -3.10% | 1,132,152 3.71% of shares | medium |
| May 7, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $5.52M | -36K -3.19% | 1,095,981 3.59% of shares | medium |
| Jun 2, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $5.51M | -39K -4.01% | 927,780 3.04% of shares | medium |
| Jun 4, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $4.57M | -33K -3.63% | 888,055 2.91% of shares | medium |
| Jun 5, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $4.39M | -36K -4.09% | 840,576 2.75% of shares | medium |
| Jun 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $4.29M | -33K -3.99% | 795,048 2.60% of shares | medium |
| Jun 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $4.29M | -33K -3.99% | 795,048 2.60% of shares | medium |
| May 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $3.96M | -26K -2.36% | 1,070,085 3.50% of shares | medium |
| May 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $3.96M | -26K -2.36% | 1,070,085 3.50% of shares | medium |
| May 11, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $3.73M | +24K +2.39% | 1,034,877 3.39% of shares | medium |
| May 11, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $3.73M | -24K -2.28% | 1,034,877 3.39% of shares | medium |
| Jun 9, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $2.43M | -19K -2.40% | 775,943 2.54% of shares | medium |
| May 11, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.96M | +13K +1.26% | 1,022,171 3.35% of shares | medium |
| May 11, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.96M | -13K -1.23% | 1,022,171 3.35% of shares | medium |
| Jun 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.58M | -13K -1.49% | 828,048 2.71% of shares | medium |
| Jun 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.58M | -13K -1.49% | 828,048 2.71% of shares | medium |
| Jun 9, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.54M | -12K -1.52% | 782,943 2.56% of shares | medium |
| Jun 5, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.50M | -12K -1.31% | 876,453 2.87% of shares | medium |
| May 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.43M | +10K +0.91% | 1,059,003 3.47% of shares | medium |
| May 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.43M | -10K -0.89% | 1,059,003 3.47% of shares | medium |
| Jun 1, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $1.03M | -7K -0.74% | 966,504 3.16% of shares | medium |
| Feb 20, 2026 | Diorio Chris Ph.d. CEO | Other | Common Stock | $951.1K | -7K -1.89% | 386,885 1.27% of shares | low |
| Jun 3, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $878.6K | -6K -0.68% | 921,467 3.02% of shares | medium |
| Feb 20, 2026 | Baker Cary Executive | Other | Common Stock | $285.8K | -2K -2.48% | 87,877 0.29% of shares | low |
| May 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $236.1K | +2K +0.15% | 1,068,525 3.50% of shares | medium |
| May 8, 2026 | Sylebra Capital LLC Director | Sell | Common Stock | $236.1K | -2K -0.15% | 1,068,525 3.50% of shares | medium |
| Mar 23, 2026 | Diorio Chris Ph.d. CEO | Other | Common Stock | $224.4K | -2K -0.57% | 390,302 1.28% of shares | low |
| Jun 23, 2026 | Diorio Chris Ph.d. CEO | Other | Common Stock | $149.9K | -1K -0.31% | 382,145 1.25% of shares | low |
| Mar 23, 2026 | Baker Cary Executive | Other | Common Stock | $74.1K | -732 -0.82% | 89,003 0.29% of shares | low |
| Jun 23, 2026 | Baker Cary Executive | Other | Common Stock | $53.1K | -424 -0.47% | 89,655 0.29% of shares | low |
| Jun 23, 2026 | Baker Cary Executive | Exercise | Common Stock | $0 | +597 +0.67% | 90,079 0.29% of shares | low |
| Jun 23, 2026 | Baker Cary Executive | Exercise | Common Stock | $0 | +479 +0.54% | 89,482 0.29% of shares | low |
| Jun 23, 2026 | Diorio Chris Ph.d. CEO | Exercise | Common Stock | $0 | +2K +0.48% | 383,342 1.25% of shares | low |
| Jun 23, 2026 | Diorio Chris Ph.d. CEO | Exercise | Common Stock | $0 | +1K +0.32% | 381,525 1.25% of shares | low |
| Jun 15, 2026 | Diorio Chris Ph.d. CEO | Gift | Common Stock | $0 | -10K -2.56% | 380,302 1.24% of shares | low |
| May 28, 2026 | Washington Miron Director | Exercise | Common Stock | $0 | +3K +152.65% | 5,154 0.02% of shares | low |
| May 28, 2026 | Gibson Daniel Patrick Director | Exercise | Common Stock | $0 | +3K +15.65% | 23,010 0.08% of shares | low |
| May 28, 2026 | Rao Meera Director | Exercise | Common Stock | $0 | +3K +37.94% | 11,322 0.04% of shares | low |
| May 28, 2026 | Padval Umesh Director | Exercise | Common Stock | $0 | +3K +87.97% | 6,654 0.02% of shares | low |
| May 28, 2026 | Sanghi Steve Director | Exercise | Common Stock | $0 | +3K +34.78% | 13,274 0.04% of shares | low |
| Mar 23, 2026 | Baker Cary Executive | Exercise | Common Stock | $0 | +597 +0.67% | 89,735 0.29% of shares | low |
| Mar 23, 2026 | Baker Cary Executive | Exercise | Common Stock | $0 | +479 +0.54% | 89,138 0.29% of shares | low |
| Mar 23, 2026 | Baker Cary Executive | Exercise | Common Stock | $0 | +782 +0.89% | 88,659 0.29% of shares | low |
| Feb 20, 2026 | Baker Cary Executive | Grant | Common Stock | $0 | +9K +10.43% | 90,111 0.29% of shares | low |
| Mar 23, 2026 | Diorio Chris Ph.d. CEO | Exercise | Common Stock | $0 | +2K +0.47% | 392,520 1.28% of shares | low |
| Mar 23, 2026 | Diorio Chris Ph.d. CEO | Exercise | Common Stock | $0 | +1K +0.31% | 390,703 1.28% of shares | low |
| Mar 23, 2026 | Diorio Chris Ph.d. CEO | Exercise | Common Stock | $0 | +3K +0.67% | 389,479 1.27% of shares | low |